Gyre Therapeutics

GYRENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$743.631 M

$6.67 +4.22%

Close of 7 Aug 2026

Revenue

$116.6M

#2467 by revenue

Earnings

$9.88M

#2051 by earnings

Shares outstanding

111,509,849

Latest filing cover page

P/E ratio

75.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#182Rigel PharmaceuticalsRIGL$750.4M
#183BridgeBio Oncology TherapeuticsBBOT$747.4M
#184Gyre TherapeuticsGYRE$743.6M
#185OculisOCS$735.2M
#186CybinHELP$719.6M

Where these numbers come from

Share counts and financials for Gyre Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.